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Cell signalingPlatelet activation triggers an imbalance in plasma membrane phospholipids by a speciﬁc aminopho-
spholipid outﬂux, resulting in ﬁlopodia formation. Similarly, the addition of a phospholipid excess in the
outer leaﬂet of the plasma membrane induces cellular extensions and actin polymerization. The implication
of membrane microdomains in sustaining these mechanical constraints remains, however, unknown and
was investigated in human platelets and mouse ﬁbroblasts. The disruption of lipid rafts by cholesterol
depletion prevents actin polymerization and formation of cellular extensions. Phospholipid excess triggers
raft patching underneath the cell extensions, recruitment of protein raft markers and increase of tyrosine
phosphorylation of raft proteins. Using a mass spectrometric analysis of isolated platelet rafts, we identiﬁed
tyrosine kinases and proteins implicated in the formation of cell membrane extensions, cell adhesion and
motility. They are recruited to rafts in response to a mechanical constraint. Taken together, our results
demonstrate that exogenous phospholipid addition causes a modulation of the lateral plasma membrane
organization and an activation of the cell signaling triggering actin remodeling and the formation of cellular
protrusions. Raft disruption abolishes these processes, demonstrating that their integrity is crucial for cell
shape changes in response to a mechanical constraint on plasma membrane.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Plasma membranes of mammalian cells are dynamic structures
characterized by the asymmetric transversal distribution of phospho-
lipids between the inner and the outer leaﬂets [1,2] and by a high
lateral mobility of proteins and lipid molecules [3]. The ability of cells
to generate regions of membrane curvature is of vital importance in
regulating changes in membrane morphology that underlie processes
such as membrane trafﬁcking and cell migration [4]. The membrane
curvature is generated as a result of a complex interplay between
membrane proteins, lipids and physical forces that are applied to the
membrane surface. In addition to cytoskeletal proteins, other proteins
containing BAR domains (e.g., amphiphysin and endophilin) or MIM
homology domains (e.g., IRSp53) contribute to the generation of
membrane curvature [5,6]. The shape of amembrane is inﬂuenced not
only by proteins but also by lipids that could generate the driving
forces to produce membrane curvature [7–10]. Like proteins, lipidsidylcholine; PE, phosphatidyl-
yclodextrin; DRMs, detergent-
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ll rights reserved.favor positive curvature (e.g., inverted-cone-shaped lipids), which
characterizes the outer leaﬂet of a membrane bud, or negative
curvature (e.g., cone-shaped lipids) as found in the inner leaﬂet of a
bud [11,12]. In fact, during platelet activation, ﬁlopodia formation is
tightly correlated with the speciﬁc aminophospholipid outﬂux
resulting in an excess of phospholipids in the outer leaﬂet of the
plasma membrane [13]. This process is dramatically impaired in the
Scott syndrome, a rare congenital bleeding disorder, in which
aminophospholipid outﬂux is disturbed [14]. Similarly, the incorpo-
ration of a lipid directly into one monolayer induces an asymmetry of
monolayer areas and thereby increases the intrinsic curvature of the
whole bilayer, causing a curling of the membrane away from the side
to which the lipid is added, thus expanding the monolayer with more
lipids and compressing the monolayer with less lipids [8–10,15–17].
To support the exerted forces, it is hypothesized that the areas of
membrane interacting with the cytoskeleton have a speciﬁc lipid
composition. These areas are enriched with cholesterol and sphingo-
lipids and form the so-calledmembranemicrodomains, also known as
detergent-resistant membranes (DRMs) or lipid rafts [18]. Experi-
ments with different cell types show, however, that DRM composition
does not always perfectly represents raft composition [19,20]. Recent
studies have suggested that lipid rafts are implicated in supporting
membrane curvature [7] and their properties are strongly inﬂuenced
by line tension [21]. Indeed, the lipid rafts are intimately linked to
curved membranes and are concentrated in ﬁlopodia [22,23].
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short-chain analogues of phospholipids (1–2% of endogenous phos-
pholipids) into the outer leaﬂet of human resting platelets or mouse
ﬁbroblast plasma membrane induces the formation of cell membrane
extensions, such as long ﬁlopodia and lamellipodia, and reversible actin
polymerization [15]. We demonstrated that a fraction of PI-3-kinase is
reversibly activated and recruited to the plasmamembrane and that Akt
is partially phosphorylated by this small phospholipid excess in the
outer leaﬂet of the plasmamembrane of resting platelets. The formation
of cellular protrusions is inhibited by two unrelated PI-3-kinase
inhibitors, wortmannin and LY294002, and by the inhibition of actin
polymerization with cytochalasin D. It is well established that lateral
assembly of glycosphingolipids and cholesterol in membrane micro-
domains form platforms for numerous cellular events, including
membrane trafﬁcking, cell signaling and adhesion [18]. Lipid rafts are
resistant to solubilization by non-ionic detergents, such as Triton X-100
at low temperature, and can be isolated by density gradient ultracen-
trifugation due to their low buoyant density. Many proteins involved in
signal transduction co-purify with lipid rafts isolated on sucrose
gradients. These include proteins attached to the outer surface of the
plasma membrane, such as glycosyl phosphatidylinositol (GPI)-linked
proteins (CD59, PLAP) [24–26] and many dual acylated cytoplasmic
proteins attached to the inner face of the plasmamembrane, such as the
Src family kinases Lck, Fyn, Lyn [27–29].
In the present work, we attempted to determine the implication of
membrane microdomains in sustaining the mechanical constraint
induced by the addition of excess phospholipid on the outer leaﬂet of
plasma membrane. Microscopic, biochemical and proteomic
approaches were performed to explore the membrane dynamics
and the mechanism of cell shape changes in response to a mechanical
constraint acting on the plasma membrane. Using these approaches,
we demonstrate that lipid rafts play a crucial role in the formation of
cellular extensions, in actin polymerization and in triggering cell
signaling in response to a mechanical constraint applied to resting
human platelets and L929 mouse ﬁbroblasts.
2. Materials and methods
2.1. Preparation of human platelets
Blood collected in 0.15 vol. of ACD buffer containing 85 mM
trisodium citrate, 111 mM dextrose, 71 mM citric acid, was obtained
from healthy volunteers. Platelets were prepared at room temperature
using the erythrocyte cushion procedure, as previously described
[30,31]. After staining with Plaxan reagent (Sobioda SA, France) and
counting, plateletswere gently resuspended in Bevers buffer containing
96 mM NaCl, 1 mM CaCl2, 2.7 mM KCl, 2 mM MgCl2, 5 mM dextrose,
50mMHEPES, pH7.4 at 2.2×109 platelets/ml. Platelets were incubated
for 30min at 37 °C (pH 7.4) before treatments. Platelets were optionally
activated at37 °Cbyadding1 IU/ml thrombin for 2 min in the presence
of 1 mM external Ca2+ (pH 7.0).
2.2. Cell culture
L-929 mouse ﬁbroblasts (CCL-1; American Type Culture Collec-
tion) were grown in RPMI 1640 with glutamax (GIBCO BRL)
supplemented with 10% fetal bovine serum, 25 IU/ml penicillin and
25 μg/ml streptomycin (GIBCO BRL) at 37 °C in the presence of 5% CO2.
They are used at ∼80% conﬂuence. For microscopy, cells were plated
onto coverslips coated with poly-L-lysine and human ﬁbronectin
(Sigma Chemical Co.). For poly-L-lysine coating, coverslips were
incubated on a drop of aqueous 100 μg/ml poly-L-lysine for 30 min at
room temperature, washed with distilled water and air dried.
Fibronectin was coated onto poly-L-lysine-treated coverslips by
incubation on a drop of 25 μg/ml ﬁbronectin in PBS at 4 °C overnight.
After rinsing in PBS, these coverslips were used without drying.2.3. Nocodazole treatment
Microtubules were depolymerized according to the method of
Kaverina and collaborators [32]. Brieﬂy, L-929 ﬁbroblasts were
trypsinized and resuspended in fresh culture medium containing
2.5 μg/ml nocodazole (Sigma Chemical Co.). Cells were immediately
plated onto coverslips or culture dishes for 3 h at 37 °C in the presence
of 5% CO2.
2.4. Incubation of L929 ﬁbroblasts and resting platelets with
phospholipid analogues
L929 ﬁbroblasts pre-treated with nocodazole (and in some cases
with MβCD) were rinsed twice in PBS and incubated with 50 μM
dilauroyl-phosphatidylcholine (DLPC; Sigma Chemical Co.) or a short-
chain spin-labeled phosphatidylserine (PS; [33]) in serum-free
medium for 2 min at room temperature with gently shaking. Platelets
at 2.2 109 cells/ml pre-treated or not with MβCD were incubated at
37 °C without shaking with PC or PS analogues at 1% of total
phospholipids as previously described [33]. After 2 and 30 min,
phospholipid incubation was stopped for further analysis.
2.5. Determination of actin ﬁlament content in platelets
Platelets were lysed by the addition of an equal volume of buffer
containing 2% Triton X-100, 10 mM EGTA and 100 mM Tris–HCl, pH
7.4. The actin ﬁlament content was determined by DNase-I inhibition
assay as described previously [34,35]. Data from three independent
experiments represent the mean±SEM. Student's t test was used for
statistical analysis. DNA and DNase-I were obtained from Sigma
Chemical Co.
2.6. Scanning electron microscopy (SEM)
Platelets were prepared as reported previously [31]. Brieﬂy
platelets were ﬁxed with 2% glutaraldehyde in a 0.1-M cacodylate
solution, pH 7.4, for 30 min at 4 °C and then treated with 1%
osmium tetroxide in a 30-mM sodium acetate, 30 mM sodium
veronal and 0.02 N HCl buffer. Thereafter, platelets were washed in
distilled water and allowed to sediment onto Thermanox coverslips
(Nunc Inc.). Samples were dehydrated through a graded alcohol
series. After drying by using the CO2 critical point method and
coating with gold, samples were observed on a Jeol 6300Fmicroscope.
Photos were assembled using Photoshop (Adobe) and PowerPoint
(Microsoft).
2.7. Raft disruption
L-929 mouse ﬁbroblasts previously pre-treated or not with
nocodazole were rinsed once in PBS and incubated with 5 mM
MβCD (Methyl-β-cyclodextrin; Sigma Chemical Co.) in serum-free
medium for 30min at 37 °C in the presence of 5% CO2. Fibroblasts were
washed twice with PBS for removing MβCD-cholesterol complexes.
For platelets raft disruption, they were incubated with 5 mMMβCD in
Bevers buffer for 10 min at 37 °C, spun at 6000 ×g for 3 min and
resuspended in Bevers buffer with or without addition of phospho-
lipid analogues.
2.8. Raft patching in L-929 ﬁbroblasts and platelets
Raft patching was performed after 8 μg/ml biotin-conjugated
cholera toxin B subunit (Sigma Chemical Co.) incubation in TBS with
0.1% BSA for 30 min at 12 °C, followed by rhodamine-conjugated
streptavidin (Sigma Chemical Co.) 1:100 in TBS with 0.1% BSA
treatment for 30 min on ice. Platelets were pre-treated or not with
MβCD (5 mM for 10 min), incubated with DLPC (1% of total PLs for
391R.M. Larive et al. / Biochimica et Biophysica Acta 1798 (2010) 389–4002 min) and ﬁxed for 30 min with 2% paraformaldehyde in PBS at room
temperature. Surface plasma membrane GM1 was detected by
biotinylated cholera toxin followed by incubation with ﬂuorescein-
conjugated Streptavidin.
2.9. Microscopy
For phase-contrast microscopy, L-929 ﬁbroblasts were treated as
described above and ﬁxed for 30 min with 2% paraformaldehyde in
PBS at room temperature. Cells were washed three times with Tris-
buffered saline (TBS) and three times with distilled water. Coverslips
were mounted with Mowiol and allowed to polymerize at 4 °C
overnight. Preparations were observed on a LEICA DMRA2 micro-
scope, using a 40× oil objective. Data were acquired using a cooled
CCD camera (Photometrics Coolsnap HQ) driven by Metamorph
software. For DIC and epiﬂuorescence microscopy, platelets were pre-
treated as described above. Observations were performed with a Zeiss
Axioimager microscope using AxioVision software for images acqui-
sition and processing.
2.10. Confocal microscopy
Cells were ﬁxed and washed with TBS as for phase-contrast
microscopy. Non-speciﬁc sites blocking and cell permeabilization
were achieved by incubation for 30 min with 1% gelatin, 0.03%
saponin in TBS at room temperature. Cells were rinsed once with 0.2%
gelatin, 0.03% saponin in TBS and incubated with appropriate
molecules. For actin labeling, 0.5 μM TRITC-conjugated phalloidin in
a buffer containing 20 mM KH2PO4, 10 mM PIPES, 5 mM EGTA, 2 mM
MgCl2 and 0.03% saponin for 30 min was used. For detecting tyrosine-
phosphorylated proteins, we used 4G10 hybridoma supernatant for
30 min followed by TRITC-conjugated donkey anti-mouse antibody.
For GM1 detection, we used 8 μg/ml FITC-conjugated cholera toxin B
subunit (Sigma Chemical Co.) for 30 min. Coverslips were washed
three times with 0.2% gelatin, 0.03% saponin in TBS between antibody
incubations. Preparations were observed on a LEICA TCS 4D confocal
laser scanning microscope, using a 40× oil objective. Data were
acquired using cooled CCD camera (Hitachi KP-161) driven by
Scanware software.
2.11. Raft isolation from L-929 ﬁbroblasts and resting platelets
L-929 ﬁbroblasts treated or not with different reagents (5–6×106
cells) were lysed by adding 4 ml of ice-cold buffer containing 1%
Triton X-100, 25 mM Tris–HCl, 150 mM NaCl, 5 mM EDTA, pH 7.5,
50 mM NaF, 1 mM Na3VO4, protease inhibitor cocktail (Boehringer
Mannheim) in culture dishes. Cells were immediately scrapped,
harvested and incubated 20 min on ice. Alternatively, resting
platelets (4.4×109 cells) were lysed by the addition of an equal
volume of buffer containing 2% Triton X-100, 10 mM EGTA and
100 mM Tris–HCl, pH 7.4, 100 mM NaF, 2 mM Na3VO4, protease
inhibitor cocktail (Boehringer Mannheim). The lysate was homoge-
nized with 10 strokes of a Dounce homogenizer. Subsequent
procedures were performed at 4 °C. The total lysate was adjusted
to 40% sucrose (in lysis buffer without Triton) and placed in the
bottom of Ultraclear ultracentrifuge tubes (Beckman Dickinson).
Four-milliliter samples of 30% sucrose (in lysis buffer without Triton)
and 1.5 ml of lysis buffer without Triton were poured above the 40%
sucrose layer. Gradients were spun for 16 h, 4 °C at 39,000 rpm
(192,000×g) in a Beckman SW40Ti rotor. Fractions of 1 ml were
collected from the top and were diluted 6-fold with buffer containing
25 mM Tris–HCl, 150 mM NaCl and 5 mM EDTA, pH 7.5, to reduce
sucrose concentration. Diluted fractions were spun for 1 h, 4 °C at
39,000 rpm (100,000×g) in a Beckman 50Ti rotor. After removing
supernatant, Triton insoluble material was solubilized in 1× electro-
phoresis sample buffer.2.12. Gel electrophoresis and immunoblotting
Proteins were separated on SDS–PAGE (10%) and detected with
Colloidal Brilliant Blue G reagent (Sigma Chemical Co.) or transferred
onto PVDF membranes (Immobilon P, Millipore, Bedford, MA). Non-
speciﬁc binding of proteins to the membrane was blocked with TBS
containing 0.05% Tween-20 (TTBS) and 5% BSA for 1 h at room
temperature. Tyrosine-phosphorylated protein staining was per-
formed using 4G10 hybridoma supernatant (1:10 in TTBS with 1%
BSA) for 1 h. CD36 and ﬂotillin-1 were revealed withmonoclonal anti-
CD36 antibody (Cat No. 0765, Immunotech) used at 1:1000 and with
monoclonal anti-ﬂotillin-1 antibody (Cat No 610821, BD Biosciences)
used at 1:100. The membranes were then incubated with horseradish
peroxidase-conjugated goat anti-mouse antibody. After three washes
with TTBS, the proteins were visualized using ECL detection reagents
and X-ray ﬁlm according to the supplier's instructions. The ganglio-
side GM1 was revealed by dot blot with biotin-conjugated cholera
toxin B subunit followed by incubation with horseradish peroxidase-
conjugated streptavidin.
2.13. In-gel digestion and MS analysis of platelet raft proteins
The proteins from 2 to 4 top fractions of Triton insoluble materials
were pooled and separated by 4–15% gradient SDS–PAGE. The gel was
stained with the Colloidal Brilliant Blue G reagent (Sigma) according
to the supplier's instructions. Protein bands were cut and in-gel
digested using trypsin (sequencing grade; Promega, Charbonnières,
France) as described [36]. Digested proteins were dehydrated in a
vacuum centrifuge, solubilized in 3 μl of formic acid (2%). Samples
(1 μl) were analyzed online on an ESI quadrupole time-of-ﬂight (Q-
TOF) mass spectrometer (QSTAR Pulsar-i, Applied Biosystems, Foster
City, CA) coupled with an Ultimate 3000 HPLC (Dionex, Amsterdam,
Netherlands). Desalting and pre-concentration of samples were
performed on-line on a Pepmap® precolumn (0.3 mm×10 mm). A
gradient consisting of 0–40% B in 60 min and 40–80% B in 15 min
(A=0.1% formic acid, 2% acetonitrile in water; B=0.1% formic acid in
acetonitrile) at 300 nl/min was used to elute peptides from the
capillary (0.075 ×150 mm) reverse-phase column (Pepmap®,
Dionex). The Q-TOF was ﬁtted with an uncoated silica PicoTip Emitter
(NewOjective, Woburn, USA) with an outlet diameter of 8 μm. Spectra
were recorded using the Analyst QS 1.1 software (Applied Biosys-
tems). Parameters were adjusted as follows: ion spray voltage (IS),
1800 V; curtain gas (CUR), 25; declustering potential (DP), 75 V;
focusing potential (FP), 265 V; and declustering potential 2 (DP2),
15 V. Spectra were acquired with the instrument operating in the
information-dependent acquisition mode throughout the HPLC
gradient. Every 7 s, the instrument cycled through acquisition of a
full-scan spectrum (1 s) and two MS/MS spectra (3 s each). Peptide
fragmentation was performed using nitrogen as collision gas (CID) on
themost abundant doubly or triply charged ions detected in the initial
MS scan, with a collision energy proﬁle optimized according to
peptide mass (using manufacturer parameters) and an active
exclusion time of 0.60 min. All MS/MS spectra were searched against
the Homo sapiens entries of either SwissProt or TrEMBl databases
(Unitrop 10.2, http://www.expasy.ch) by using the Mascot v 2.1
algorithm (http://www.matrixscience.com). Identiﬁcation was done
on the basis of at least one speciﬁc peptide. All signiﬁcant hits
(pb0.05) were manually inspected.
3. Results
3.1. Lipid raft integrity is necessary for PL excess-induced actin
rearrangement in resting platelets
Wehave already shown that the addition of small amount (1–2% of
total phospholipids) of short-chain phospholipid analogues to the
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L929 ﬁbroblasts generates reversible ﬁlopodia and plasma membrane
extensions [15]. The added phospholipid analogue is uniformly
distributed in the outer leaﬂet of the plasma membrane. We have
shown that ﬁlopodia formation in platelets induced by thrombin or
Ca2+-ionophore A23187 (which triggers platelet activation) or by PC
(which does not trigger platelet activation) was inhibited by
cytochalasin D (an inhibitor of actin polymerization) but not
nocodazole (a microtubule disrupting agent that did not induce
serotonin secretion). According to this observation, ﬁlamentous actin
quantiﬁcation by DNase-I inhibition assay revealed that phospholipid
excess induced actin polymerization in a PI 3-kinase-dependent
manner [15]. In this study, we show that the disruption of lipid rafts
by cholesterol depletion in resting human platelets prevents ﬁlopodia
formation, as observed by scanning electronmicroscopy (Fig. 1A), andFig. 1. Implication of cholesterol in ﬁlopodia extension and actin polymerization induced
micrographs showing the representative morphology of resting platelets (CTRL); platelets
methyl beta cyclodextrin (MβCD); platelets pre-treated with MβCD and then incubated with
independent experiments. Scale bar, 3 μm. (B) Induction of actin polymerization by excess ph
determined by the DNase 1 inhibition assay as indicated in the Materials and methods secti
platelets incubated with PC for 2 min; MβCD, the actin ﬁlament content in resting platelets t
MβCD before their incubation with PC for 2 min. Error bars indicate SEM (n=3). ⁎pb 0.01prevents actin polymerization and remodeling, as showed by DNase-I
inhibition assay (Fig. 1B). Cholesterol depletion by methyl-β-
cyclodextrin (MβCD) in resting human platelets did interfere neither
with the cell morphology (Fig. 1A, MβCD) as compared to the control
(Fig. 1A, Ctrl) nor with the F-actin content (Fig. 1B, MβCD) as
compared to the control (Fig. 1B, Ctrl). However, the cholesterol
depletion before the addition of phospholipid excess to the outer
leaﬂet inhibits ﬁlopodia formation (Fig. 1A, MβCD+PC) as compared
to resting platelets incubated with phospholipid excess without
cholesterol depletion (Fig. 1A, PC). In the same manner, actin
polymerization induced by phospholipid excess (Fig. 1B, PC) was
completely abolished in resting platelets pre-treated with MβCD
before phospholipid addition (Fig. 1B, MβCD+PC). Taken together,
these data indicate that cholesterol and lipid raft integrity are
important for platelet response (ﬁlopodia formation and actinby a phospholipid excess in the platelet plasma membrane. (A) Scanning electron
incubated with phosphatidylcholine (PC) for 2 min; resting platelets pre-treated with
PC 2 min (MβCD+PC). Micrographs are representative for the cells from at least three
ospholipids in resting platelets. Actin ﬁlament content in different platelet extracts was
on. Ctrl, the actin ﬁlament content in resting platelets; PC, the actin ﬁlament content in
reated with MβCD; MβCD+PC, the actin ﬁlament content in platelets pre-treated with
vs. CTRL; †pb 0.01 vs. MβCD+PC.
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lipid excess.
3.2. Lipid rafts concentrate underneath the cellular extensions induced
by a phospholipid excess in ﬁbroblasts
To visualize lipid rafts in L929 ﬁbroblasts submitted to a
mechanical constraint, cells were plated onto coverslips coated with
poly-L-lysine and ﬁbronectin. To remove pre-existing cellular exten-
sions involved in cell adhesion and locomotion, ﬁbroblasts were
treatedwith nocodazole, which depolymerizes microtubules [32]. The
nocodazole-treated ﬁbroblasts are shown in Fig. 2 (Noco) and the
control ﬁbroblasts are shown in Fig. 2 (Ctrl). The cells were then
incubated with a phospholipid excess (Fig. 2A, Noco+PC). Alterna-
tively, the cholesterol of the plasma membrane was ﬁrst depleted by
incubating the cells with MβCD (Fig. 2A, Noco+MβCD+PC). The
ﬁbroblasts were ﬁxed without permeabilization and the GM1
ganglioside raft marker was patched with biotin-conjugated cholera
toxin B subunit and revealed with rhodamine-conjugated streptavi-
din. The cells were observed with phase-contrast and ﬂuorescence
microscopy. In this experiment, the mechanical constraint caused by
the addition of an excess of phospholipids induces cellular extensions
in nocodazole-treated ﬁbroblasts and the GM1 lipid raft marker forms
punctuate sites in the plasma membrane sustaining the membrane
extensions (Fig. 2A, Noco+PC). However, when the cholesterol was
depleted, themembrane extensions induced by a phospholipid excess
were impaired and GM1 was homogeneously distributed all over the
plasma membrane (Fig. 2A, Noco+MβCD+PC) in the same manner
as the nocodazole-treated ﬁbroblasts without any other treatment
(Fig. 2A, Noco). We performed the same experiment with plateletsFig. 2. Patching of lipid rafts underneath the plasmamembrane extensions induced by a phos
microscopy micrographs of untreated L929 ﬁbroblasts (Ctrl); L929 ﬁbroblasts incubated for
for 3 h at 37 °C in the presence of 2.5 μg/ml nocodazole and subsequently treated with PC fo
2.5 μg/ml nocodazole and 5 mM MβCD for 30 min at 37 °C and then treated with PC for 2 m
platelets untreated (Ctrl) or treated with PC for 2 min (PC), with or without MβCD incubatio
biotin-conjugated cholera toxin B subunit and rhodamine-conjugated streptavidin (for ﬁbro
Pictures are representative of the cells from three independent experiments. Scale bars, 10(Fig. 2B). The addition of phospholipids induces formation of ﬁlopodia
in which the raft marker GM1 is localized (Fig. 2B, PC). The formation
of ﬁlopodia and the GM1 localization in ﬁlopodia were abolished by
MβCD treatment (Fig. 2B, MβCD+PC).
These results indicate that the lipid raft integrity is essential for the
ﬁbroblast response to a mechanical constraint and that lipid rafts
accumulate underneath the cellular extensions after addition of
excess phospholipid to the outer leaﬂet of ﬁbroblast and platelet
plasma membrane.
3.3. Mechanical constraint triggers actin remodeling and protein tyrosine
phosphorylation in cellular extensions of ﬁbroblasts via lipid rafts
To investigate the consequences of a mechanical constraint on the
actin cytoskeleton and the protein tyrosine phosphorylation in L929
ﬁbroblasts, we incubated these cells with phospholipid excess.
Implication of lipid rafts in these responses is tested by a prior
cholesterol depletion. To detect F-actin and tyrosine-phosphorylated
proteins, cells were permeabilized with saponin that does not affect
the clustering of the ganglioside GM1 as we obtained a staining of the
cytosol and nearby cell membrane extensions (Fig. 3B, Noco+PC).
Induced membrane extensions are maintained as evidenced by a
strong actin polymerization (Fig. 3A, Noco+PC) and are enriched in
tyrosine-phosphorylated proteins (Fig. 3B, Noco+PC). These mem-
brane extensions, the actin remodeling and the enhanced tyrosine
phosphorylation are dependent of the integrity of lipid rafts. Indeed,
treatment with MβCD prevents membrane extensions, actin poly-
merization (Fig. 3A, Noco+MβCD+PC), tyrosine phosphorylation
and GM1 clustering (Fig. 3B, Noco+MβCD+PC). Our results
demonstrate that lipid rafts play a crucial role in phospholipidpholipid excess in ﬁbroblasts and platelets. (A) Merge of phase-contrast and ﬂuorescent
3 h at 37 °C in the presence of 2.5 μg/ml nocodazole (Noco); L929 ﬁbroblasts incubated
r 2 min (Noco+PC); and L929 ﬁbroblasts incubated for 3 h at 37 °C in the presence of
in (Noco+MβCD+PC). (B) Merge of DIC and ﬂuorescent microscopy micrographs of
n (MβCD, MβCD+PC). The cells were ﬁxed and the GM1 ganglioside was detected with
blasts) or ﬂuorescein-conjugated streptavidin (for platelets) without permeabilization.
μm.
Fig. 3. Actin remodeling and tyrosine phosphorylation induced by phospholipid excess in ﬁbroblasts. Confocal micrographs of L929 ﬁbroblasts incubated for 3 h at 37 °C in the
presence of 2.5 μg/ml nocodazole (Noco); L929 ﬁbroblasts incubated for 3 h at 37 °C in the presence of 2.5 μg/ml nocodazole and subsequently treated with PC for 2min (Noco+PC);
and L929ﬁbroblasts incubated for 3 h at 37 °C in the presence of 2.5 μg/ml nocodazole and 5mMMβCD for 30min at 37 °C and then treatedwith PC for 2min (Noco+MβCD+PC). (A)
The cells were ﬁxed and permeabilized and F-actin was labeled with phalloidin-TRITC. (B) Alternatively the GM1 ganglioside and the tyrosine-phosphorylated proteins were labeled,
respectively, with cholera toxin B subunit-FITC and with the mouse monoclonal 4G10 anti-phospho-tyrosine antibody revealed with anti-mouse IgG-rhodamine. The arrowheads in
the inset of panels Noco+PC indicate the co-localization of GM1 ganglioside and tyrosine-phosphorylated proteins. Pictures are representative of the cells from three independent
experiments. Scale bars: 10 μm.
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events, such as actin polymerization and tyrosine phosphorylation.
3.4. Phospholipid excess in the outer leaﬂet induces the reversible
enrichment of raft markers and tyrosine phosphorylation of several lipid
raft proteins in resting platelets and ﬁbroblasts
To evaluate the effects of the applied mechanical constraint on the
outer leaﬂet of the plasma membrane of resting platelets and L929ﬁbroblasts at the biochemical level, we proceeded to a fractionation of
the cells that were subjected to different treatments and isolated the
DRM fractions containing lipid rafts. After incubation with a
phospholipid excess, consisting of short-chain analogues of phos-
pholipids (PS and PC), resting platelets (Fig. 4) and L929 ﬁbroblasts
(Fig. 5), depleted (with MβCD) or not (without MβCD) in cholesterol,
were lysed after respectively 2 and 30 min of incubation with the
phospholipid analogues. The different fractions obtained by ultracen-
trifugation on a sucrose gradientwere analyzed for their content in raft
Fig. 4. Distribution of the raft markers and consequences of cholesterol depletion in platelets subjected to phospholipid excess. Platelets were incubated with excess phospholipids
(PS or PC) pre-treated or not with MβCD. The raft and non-raft fractions were separated by a sucrose gradient equilibrium centrifugation of Triton X-100 platelet lysates. (A) Dot blot
analysis of ganglioside GM1 distribution in separated fractions of lysed platelets under the indicated conditions of treatment. (B) Western blot analysis of CD36 distribution in
separated fractions of lysed platelets under the same conditions of treatment as in A. (C) Western blot analysis of tyrosine-phosphorylated protein distribution in different fractions
of lysed platelets under the indicated treatment conditions. Molecular weights are indicated on the left side of the blots. Data are representative of three independent experiments.
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Fig. 5. Distribution of raft markers and consequences of the cholesterol depletion in L929 ﬁbroblasts subjected to phospholipid excess. The ﬁbroblasts were incubated with excess
phospholipids (PC) pre-treated or not with MβCD. The raft and non-raft fractions were separated by a sucrose gradient equilibrium centrifugation of Triton X-100 ﬁbroblast lysates.
(A) Dot blot analysis of ganglioside GM1 distribution in separated fractions of lysed ﬁbroblasts under the indicated treatment conditions. (B) Western blot analysis of ﬂotillin-1
distribution in separated fractions of lysed ﬁbroblasts under the same conditions of treatment as in A. (C) Western blot analysis of the tyrosine-phosphorylated protein distribution
in separated fractions of lysed ﬁbroblasts under the indicated treatment conditions. Molecular weights are indicated on the left side of the blots. Data are representative of three
independent experiments.
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ﬁbroblasts in Fig. 5) and in tyrosine-phosphorylated proteins (Figs. 4
and5, P-Tyr). In Fig. 4A, the addition of phospholipid analogues (PS and
PC) after 2 min of incubation induces enrichment of the ganglioside
GM1 in raft fractions (Fig. 4A, PS 2min andPC 2min) andCD36 (Fig. 4B,
PS 2minandPC2min) as compared tountreatedplatelets (Figs. 4A and
B, Ctrl). After 30min incubationwith the phosphatidylserine analogue,
GM1andCD36 are less enriched, demonstrating the reversibility of this
process (Fig. 4A andB, PS 30min). PS is known to be translocated to the
inner leaﬂet by the aminophospholipid translocase, termed ﬂippase
[37]. Consequently, after 30min incubation, the phospholipid excess in
the outer leaﬂet does not persist. Conversely, GM1 is still enriched in
the raft fractions after 30 min of incubation with the PC analogue (Fig.
4A, PC 30 min). For unknown reasons, CD36 is not maintained to the
same extent as GM1 in these fractions (Fig. 4B, PC 30min). As PC is not
spontaneously translocated to the inner leaﬂet, the phospholipid
excess in the outer leaﬂet of plasma membrane persists after 30 min.
This demonstrates that the enrichment of GM1 in raft fractions requires
a phospholipid excess in the outer leaﬂet of the membrane, which is
persistentwith phosphatidylcholine analogue treatment but reversible
with phosphatidylserine analogue treatment. The cholesterol deple-
tion by MβCD treatment abolishes this enrichment of GM1 and CD36
independent of the platelet treatment. As positive control, we used
platelets activated by thrombin, which is known to enrich ganglioside
GM1 and CD36 in the raft fractions (Fig. 4A and B, Thrombin) [38]. This
enrichment was abolished by the depletion of cholesterol (Fig. 4A and
B, MβCD+Thrombin). Furthermore, the mechanical constraint
increases the tyrosine phosphorylation of proteins found in DRMfractions (Fig. 4C, PS 2 min, PC 2 min, PC 30 min and Thrombin).
Interestingly, this enrichment is reversible when the phosphatidylser-
ine analogue is added (Fig. 4C, PS 30 min), as it is translocated to the
inner leaﬂet by the ﬂippase [37] and is abolished byMβCD-cholesterol
depletion (Fig. 4C). The bands exhibiting a decreased phosphorylation
after thrombin treatment may be the consequence of the activation
of protein tyrosine phosphatases. For example, the receptor-type
protein tyrosine phosphatase B has been identiﬁed in the proteomic
analysis after phospholipid addition (Table S1). The different
phospho-tyrosine patterns obtained after thrombin and PL treat-
ments most likely reﬂect the diverse signaling pathways activated by
these treatments in platelets.
As in resting platelets, the addition of an excess of phospholipids to
L929 ﬁbroblasts induces enrichment of ganglioside GM1 and ﬂotillin-
1 to DRM fractions (Fig. 5A and B, PC 2 min) compared to the control
cells (Fig. 5, Ctrl). The ﬂotillin-1 enrichment is abolished when the
ﬁbroblasts were pre-treated with MβCD (Fig. 5B, MβCD+PC 2 min).
The ganglioside GM1 level in theMβCD+PC-treated samples exhibits
a 1.56-fold (SDb0.05) decrease as compared to PC, as quantiﬁed by
densitometry (Image J, http://rsbweb.nih.gov/ij/) (Fig. 5A, MβCD+
PC 2 min). Moreover, the mechanical constraint imposed to
ﬁbroblasts increases the tyrosine phosphorylation of the proteins of
DRM fractions in a cholesterol-dependent manner (Fig. 5C). Taken
together, these biochemical results indicate that a mechanical
constraint applied to the plasma membrane of resting platelets and
L929 ﬁbroblasts triggers a reorganization of the membrane micro-
domains (enrichment of GM1, CD36 and ﬂotillin-1 in DRM fractions)
and an increase in tyrosine phosphorylation in a reversible manner.
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platelets. Cholesterol depletion reduces phospholipid excess-driven
cell signaling showing that lipid raft integrity is necessary for
sustaining the generated membrane extensions.
3.5. Proteomic analysis of the enriched DRM proteins from the resting
platelets subjected to a phospholipid excess
To analyze the proteins enriched in lipid rafts after the addition of
phospholipids to the outer leaﬂet of the platelet plasma membrane,Fig. 6. Proteomic analysis of raft proteins in platelets subjected to a phospholipid excess. (A) T
or not with MβCD. The raft proteins were enriched by a sucrose gradient equilibrium centrifu
fractions obtained from the control platelets (Ctrl) and from the platelets subjected to ph
Colloidal Blue. Protein bands enriched after PC incubation (red arrowheads) were cut out
analyzed by Western blot in DRM fractions and in total lysate. (C) Subcellular localization of
raft proteins highlighting their association status with cellular membranes (integral, linked b
which identiﬁed raft proteins are involved.the proteins in the light buoyant-density DRM fractions of resting
human platelets incubated or not with a phospholipid excess and pre-
treated or not with MβCD were pooled and separated by SDS–PAGE
(Fig. 6A). The mechanical constraint generates a global protein
enrichment in DRM fractions as illustrated by the Coomassie staining
(Fig. 6A, PC). This enrichment is abolished by the depletion of
cholesterol (Fig. 6A, MβCD+PC). The enriched protein bands were
cut out and processed for identiﬁcation bymass spectrometry (Fig. 6A,
red arrowheads). Those displaying no increase in Coomassie staining
were not analyzed (Fig. 6A, black arrowheads). To verify that this DRMhe platelets were incubated or notwith an excess of phospholipids (PC) and pre-treated
gation of Triton X-100 platelet lysates. The 4–15% gradient SDS–PAGE gel of pooled raft
ospholipid excess (PC) pre-treated or not with MβCD (MβCD+PC) was stained with
, digested by trypsin and analyzed by mass spectrometry. (B) CD36 distribution was
raft proteins identiﬁed by mass spectrometry. (D) Molecular classiﬁcation of identiﬁed
y a lipid anchor, associated or not with cellular membranes). (E) Biological processes in
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platelet proteins before (Fig. 6B, Total lysate) or after (Fig. 6B, DRM
fractions) sucrose fractionation were subjected to SDS–PAGE and the
presence of CD36 was analyzed by Western blot. In DRM fractions,
CD36 is enriched after addition of phospholipid analogue (PC),
depending on cholesterol depletion (PC+MβCD). In total lysates,
CD36 presence is equal in all three conditions.
Using this methodology, we have identiﬁed 314 DRM-associated
proteins. One hundred sixteen (37%) of the identiﬁed proteins are
associated with the plasma membrane, 66 (21%) are cytoplasmic, 50
(16%) are mitochondrial and the remaining identiﬁed proteins areTable 1
Listing of selected raft proteins in platelets subjected to phospholipids excess




• Kinases and platelet raft signalisation proteins
cAMP-dependent protein kinase
type I-alpha regulatory subunit
P10644 Kinase (Ser/Thr)
fyn P06241 Kinase (Tyr)
lyn P07948 Kinase (Tyr)
Src P12931 Kinase (Tyr)
LAT O43561 Protein binding
LAT2 Q9GZY6 SH2 domain binding
Flotillin-1 O75955 Protein binding
Flotillin-2 Q14254 Protein binding
Raftlin Q14699 Protein binding
• Proteins involved in cellular extensions
Filamin alpha P21333 Cytoskeletal protein
ARP3 P61158 Cytoskeletal protein




Rho, GDP dissociation inhibitor
(GDI) beta
P52566 GTPase activator
Duet (kalirin Rho GEF isoform) Q9Y2A5 GEF/kinase (Ser/Thr)
Coronin-1A P31146 Cytoskeletal protein
Cortactin Q14247 Cytoskeletal protein




• Proteins involved in cell adhesion
PECAM 1 P16284 Adhesion molecule
Endothelial cell adhesion molecule Q96AP7 Adhesion molecule
Ephrin B1 P98172 Adhesion molecule
Integrin alpha 6 P23229 Adhesion molecule
Integrin beta 1 P05556 Adhesion molecule
Integrin beta 3 P05106 Adhesion molecule
Junctional adhesion molecule A Q9Y624 Adhesion molecule




Plectin 1 Q15149 Cytoskeletal protein
Parvin beta Q9HBI1 Cytoskeletal protein
Talin 1 Q9Y490 Cytoskeletal protein
vinculin P18206 Cytoskeletal protein
RhoA P61586 GTPase
• Proteins involved in platelet activation / blood coagulation
CD36 (Platelet glycoprotein 4) P16671 Protein binding
CD9 antigen (tetraspanin-29) P21926 Protein binding
Fibrinogen alpha chain P02671 Protein binding
Fibrinogen B beta chain P02675 Protein binding
Glycoprotein 5 P40197 Protein binding
Glycoprotein 6 Q9HCN6 Collagen binding
Glycoprotein 9, platelet P14770 Protein binding
Glycoprotein Ib alpha chain P07359 Thrombin receptor
Glycoprotein Ib beta chain P13224 Protein binding
Guanine nucleotide-binding
protein G(q) alpha subunit
P50148 GTPase
Integrin alpha-IIb P08514 Protein binding
Multimerin 1 Q13201 Secreted polypeptide
Phospholipid scramblase 4 Q9NRQ2 Scramblase
Platelet basic protein P02775 Cytokine
Thrombospondin 1 P07996 Protein bindingdistributed within different organelles (Fig. 6C). The membrane
proteins are distributed as follows: 34% are integral, 19% are
membrane associated and 16% are lipid anchored (Fig. 6D).
Concerning their function, 16% are involved in signal transduction,
15% in cytoskeleton, adhesion andmotility, 14% in energy metabolism
and protein transport, 6% in immune response and 5% in platelet
regulation (Fig. 6E). The identiﬁed proteins include tyrosine kinases
and platelets raft signaling proteins (e.g., fyn, lyn, src, LAT and
ﬂotillin), proteins associated with cellular extensions (e.g., Arp3,
cdc42, rac1, rhoG and moesin), involved in cell adhesion (e.g.,
integrins alpha 6, beta 1 and 3 and vinculin) or platelet activation
and blood coagulation (e.g., CD9, CD36, ﬁbrinogen, glycoproteins 5, 6
and 9 and phospholipid scramblase 4) (Table 1). The complete list of
identiﬁed proteins is detailed in the Table S1. The method we used
does, however, not exclude the identiﬁcation of certain non-raft
speciﬁc proteins. Our analysis, however, revealsmany proteins known
to be associatedwith a raft “signature” (e.g., ephrin B1, ﬂotillin-1 and -
2, fyn/lyn/src, raftlin, LAT, LAT 2, CD36, CD9, PECAM-1, stomatin, Rab
11A, Ral-A, etc.) thereby comforting our results. Conversely, certain
identiﬁed non-raft speciﬁc proteins (e.g., mitochondrial components)
are clearly discernible. Interestingly, some of the enriched proteins
(e.g., protein tyrosine kinases and cytoskeletal proteins) are related to
the phospholipid excess-driven cell signaling, reinforcing the idea
that lipid rafts are necessary to sustain the cellular extensions in
response to a mechanical constraint.
4. Discussion
We have previously shown that the addition of a phospholipid
excess to the outer leaﬂet of the plasma membrane of resting human
platelets and mouse ﬁbroblasts induces the formation of cellular
extensions (ﬁlopodia and lamellipodia) and a reversible actin
polymerization via phosphoinositide 3-kinase activation [15]. These
data corroborate the relationship between the mechanical constraint
acting on plasma membrane, cell shape changes and cytoskeleton
reorganization [39].
Several studies demonstrated the implication of lipid rafts in
various cellular processes such as protein sorting, signal transduction,
endocytosis and phagocytosis. In the present study, we have
investigated the function of lipid rafts as signaling platforms in
response to a mechanical constraint induced by the addition of
phospholipids to the outer leaﬂet of the plasma membrane of resting
human platelets and mouse ﬁbroblasts. Using MβCD, a cytochemical
probe that binds selectively to cholesterol and disrupts cholesterol-
rich microdomains, we provide evidence that lipid rafts are crucial to
maintain the mechanical constraint and act as dynamic structures
involved in the reorganization of the cytoskeleton and the formation
of plasma membrane extensions. Cholesterol depletion impedes
formation of cellular extensions and actin polymerization induced
by a phospholipid excess in resting platelets (Fig. 1) and L929
ﬁbroblasts (Figs. 2 and 3). These results reinforce the idea that lipid
rafts participate actively in membrane dynamics and actin reorgani-
zation [40,41].
The relationship between a mechanical constraint applied to the
plasma membrane and cell signaling remains, however, unknown. In
this study, we showed that mechanical constraint induces protein
tyrosine phosphorylation in the generated cellular extensions (Fig. 3)
and in DRM fractions (Figs. 4 and 5). Moreover, the GM1 ganglioside
raft marker accumulates in plasma membrane extensions generated
by a mechanical constraint (Figs. 2 and 3). An excess of phospholipids
induced an enrichment of raft markers such as ganglioside GM1, CD36
and ﬂotillin-1 that is reversible [42–44]. When the mechanical
constraint is maintained on the cell surface in the case of a
phosphatidylcholine analogue treatment (that is not translocated by
the aminophospholipid translocase to the inner leaﬂet of the plasma
membrane), the recruitment of raft markers, the protein tyrosine
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are prolonged. However, when the phospholipids are translocated to
the inner leaﬂet, as after treatment with a phosphatidylserine
analogue, these processes progressively disappear (Fig. 4). This
reversibility highlights the predominant role of the mechanical
constraint in these events. Together, our results suggest that the
addition of phospholipids causes modulation of the plasma mem-
brane lateral organization and raft protein tyrosine phosphorylation.
The disruption of lipid rafts abolishes these processes, demonstrating
that the integrity of lipid rafts is crucial for cell signaling in response to
a mechanical constraint on the plasma membrane. Moreover, the
same effects were obtained with platelets activated by thrombin,
reinforcing the link between mechanical constraint and signaling.
The recruitment and concentration of lipid rafts underneath the
plasma membrane extensions with speciﬁc enrichment of tyrosine
phosphorylation are in agreement with the observation that accumu-
lation of lipid rafts at the edge of spreading platelets, extended tips and
ﬁlopodia in activated platelets coincides with the recruitment of c-Src,
CD63 and integrins GPIbα and GPVI [23,45]. In this study, we
investigated for the ﬁrst time the recruitment and enrichment of
proteins in platelet rafts under a mechanical constraint by a proteomic
approach. Themajority of proteins display enrichment in DRM fractions
after the addition of phospholipids. This process requires lipid raft
integrity as cholesterol depletion completely abolishes the increase of
protein bands as judged by a Coomassie staining (Fig. 6). From the 314
identiﬁed proteins, amajor part is implicated in signal transduction, cell
adhesion and motility and formation of cell membrane extensions.
Sixteen percent of the identiﬁed proteins are mitochondrial and are
most likely artefacts from of the biochemical raft puriﬁcation, as was
observed also by Foster and collaborators [46]. However, more than 66%
of the proteins are related to plasma membranes, either integral, lipid
anchored or associated. Among these, the majority are described as
plasmamembrane proteins. We also observed the presence of proteins
involved in signal transduction. The identiﬁed tyrosine kinases,
signaling proteins and proteins associated with plasma membrane
extensions couldbe related to thephospholipid excess-driven cell shape
changes. Indeed, the recruitment of these signaling proteins could
induce actin polymerization. Arp3 points toward the presence of the
actin branching and nucleating Arp2/3 complex that could be activated
by its binding to cortactin, a protein phosphorylated by Src family
tyrosine kinases, thus regulating the formation of branched actin
networks [47]. The Rho family GTPase Cdc42 could also indirectly
regulate Arp2/3 [48]. The ERM protein moesin acts as a crosslinker
between actin ﬁlaments and the plasma membrane via its interaction
with PECAM 1 [49]. Another enriched protein is raftlin, which has been
described as necessary for BCR signal transduction [50]. Furthermore,
the identiﬁcation of proteins involved in platelet activation and blood
coagulation in mechanical-constrained platelets is in agreement with
the results obtainedwith thrombin-activatedplatelets [38]. A remaining
concern is to construct unambiguousmodels of protein behavior in lipid
rafts and to discriminate between non-exclusive situations. For
example, (i) proteins may already be localized in (small) lipid rafts of
resting platelets and the mechanical constraint could induce coales-
cence of these small units, increasing the efﬁciency of their puriﬁcation
on a sucrose gradient. The tyrosine phosphorylation could then arise
from kinases activated after a mechanical constraint and substrates
already localized in the small lipid rafts of resting platelets. (ii) Lipid raft
protein composition could bedifferent between resting and constrained
platelets and phospholipid excess could trigger a recruitment of speciﬁc
proteins in lipid raft fractions. Tyrosinephosphorylation could induce an
increase in the afﬁnity between transient and permanent lipid raft
proteins. This question could be addressed with a quantitative
proteomic approach and will be the aim of future studies. Another
crucial point concerns the distinction between of lipid/lipid versus
protein/lipid and protein/protein interactions and inner versus outer
leaﬂets of lipid bilayer membranes. In this study, we presentbiochemical evidence for a link between the mechanical constraints,
the clustering of lipid rafts of the outer leaﬂet and the induction of
signaling close to the inner leaﬂet of lipid rafts.
In conclusion, themorphological changes (ﬁlopodia and lamellipodia),
the reversible actin polymerization and the activation of signaling
proteins are associated with plasma membrane integrity, which is
maintained by the cholesterol homeostasis. They are intimately linked
with lipids rafts that areessential for the response toexternal forces. These
observations support the notion that enrichment of tyrosine-phosphor-
ylated proteins beneath the cellular extensions in response to a
mechanical constraint is, at least in part, due to the integrity of lipids
rafts. Our results not only strengthen the role of lipid rafts as signaling
platforms but also as dynamic structures involved in the genesis of
membrane extension in response to mechanical and external forces.
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